Lavrenkov K - Search Results

1

Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study.

Kian W, Zemel M, Kestenbaum EH, Rouvinov K, Alguayn W, Levitas D, Ievko A, Michlin R, Abod MA, Massalha I, Chernomordikov E, Sharb AA, Shalata W, Levison E, Roisman LC, Lavrenkov K, Peled N, Nesher L, Yakobson A. Kian W, et al. Among authors: lavrenkov k. Medicine (Baltimore). 2022 Jan 14;101(2):e28561. doi: 10.1097/MD.0000000000028561. Medicine (Baltimore). 2022. PMID: 35029223 Free PMC article.

2

Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult Medulloblastoma.

Kian W, Roisman LC, Goldstein IM, Abo-Quider A, Samueli B, Wallach N, Alguayn F, Shalata W, Levitas D, Belochitski O, Levin D, Fenig E, Lavrenkov K, Tokar M, Peled N, Yakobson A. Kian W, et al. Among authors: lavrenkov k. JCO Precis Oncol. 2020 Apr 30;4:PO.19.00264. doi: 10.1200/PO.19.00264. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923880 Free PMC article. No abstract available.

3

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy.

Yakobson A, Alguayn W, Shalata W, Levin D, Kian TA, Korngreen A, Gibbs R, Salah MA, Benzion S, Lavrenkov K, Roisman LC, Dudnik Y, Peled N, Refaely Y, Kian W. Yakobson A, et al. Among authors: lavrenkov k. Case Rep Oncol. 2021 Mar 3;14(1):309-317. doi: 10.1159/000510806. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33776722 Free PMC article.

4

A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Krauthamer M, Rouvinov K, Ariad S, Man S, Walfish S, Pinsk I, Sztarker I, Charkovsky T, Lavrenkov K. Krauthamer M, et al. Among authors: lavrenkov k. Oncology. 2013;85(1):27-32. doi: 10.1159/000348385. Epub 2013 Jun 29. Oncology. 2013. PMID: 23816828

5

Retrospective comparison of two different schedules of irinotecan, 5-fluorouracil and folinic acid in previously untreated patients with advanced colorectal carcinoma: a single institution experience.

Gluzman A, Rubinov K, Mermershtain W, Man S, Ariad S, Lavrenkov K. Gluzman A, et al. Among authors: lavrenkov k. J Chemother. 2007 Dec;19(6):739-43. doi: 10.1179/joc.2007.19.6.739. J Chemother. 2007. PMID: 18230559

6

Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.

Chernobelski P, Lavrenkov K, Rimar D, Riesenberg K, Schlaeffer F, Ariad S, Mermershtain W. Chernobelski P, et al. Among authors: lavrenkov k. Chemotherapy. 2006;52(4):185-9. doi: 10.1159/000093036. Epub 2006 May 2. Chemotherapy. 2006. PMID: 16675902

7

Phase II study of weekly high dose fluorouracil in previously treated patients with metastatic colorectal cancer.

Mermershtain W, Lavrenkov K, Cohen Y. Mermershtain W, et al. Among authors: lavrenkov k. J Chemother. 2000 Apr;12(2):183-5. doi: 10.1179/joc.2000.12.2.183. J Chemother. 2000. PMID: 10789559 Clinical Trial.

8

Ethnic variation in toxicity and outcome of adjuvant chemoradiation for gastric cancer in Israel.

Brenner RM, Kivity S, Kundel Y, Purim O, Peled N, Idelevich E, Lavrenkov K, Kovel S, Fenig E, Sulkes A, Brenner B. Brenner RM, et al. Among authors: lavrenkov k. Anticancer Res. 2013 Nov;33(11):5151-7. Anticancer Res. 2013. PMID: 24222163

9

Retrospective comparison of single-agent chemotherapy with weekly 5-fluorouracil or weekly irinotecan in previously treated patients with metastatic colorectal cancer.

Lavrenkov K, Man S, Mermershtain W, Cohen Y. Lavrenkov K, et al. J Chemother. 2002 Feb;14(1):84-7. doi: 10.1179/joc.2002.14.1.84. J Chemother. 2002. PMID: 11892905

10

The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.

Brenner A, Friger M, Geffen DB, Kaisman-Elbaz T, Lavrenkov K. Brenner A, et al. Among authors: lavrenkov k. Oncology. 2019;97(5):255-263. doi: 10.1159/000500926. Epub 2019 Jul 9. Oncology. 2019. PMID: 31288238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page